Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study
Crossref DOI link: https://doi.org/10.1007/s11060-014-1684-y
Published Online: 2014-12-23
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahluwalia, Manmeet S.
Xie, Hao
Dahiya, Saurabh
Hashemi-Sadraei, Nooshin
Schiff, David
Fisher, Paul G.
Chamberlain, Marc C.
Pannullo, Susan
Newton, Herbert B.
Brewer, Cathy
Wood, Laura
Prayson, Richard
Elson, Paul
Peereboom, David M.
Text and Data Mining valid from 2014-12-23